Literature DB >> 32335174

Clinical Features and Outcomes of Asymptomatic Cases of SARS-CoV-2 Infection.

Jianguo Wu1, Jun Liang1, Hongji Zhou2, Fengying Peng2, Bin Wang2, Wei Jiang2, Bei Jia3, Tao Luo4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32335174      PMCID: PMC7179485          DOI: 10.1016/j.jinf.2020.04.027

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
Dear Sir, We read with great interest the paper of Wenjie Yang et al. on “Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China” that allow us to share our experiences and observations during the past several months. COVID-19 is a new emerging infectious disease globally. Current understanding on its pathogen termed as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is limited. The virus is thought to mainly transmit from person to person by air droplets and close contact. Essential steps of controlling this disease focus on early detection and isolation of the confirmed cases, followed by tracing and screening their contacts, which is fundamental for minimizing the risk of spread, specifically the isolation and management of the asymptomatic cases. Previous report has demonstrated the existence of incomplete clinical presentations of SARS, 80% genetically similarity with SARS-CoV-2. We found 15 asymptomatic cases who were tested positive by RT-PCR assay during the contact-screening of the confirmed COVID-19 patients in Fengjie county, northeastern Chongqing, where is adjacent to Hubei, the center of COVID-19 outbreak in China. Fifteen people in the absence of complaints were tested positive by twice real time reverse transcription-polymerase chain reaction (RT-PCR) method through nasopharygeal or rectal swabs. All of these cases were either family members or close contacts with certain confirmed cases either symptomatic or asymptomatic, consisting of five males and ten females. The age ranged from 5 to 76 years old. We did not see any significant alternation of WBC, lymphocytes, PLT, CRP and PCT as previous described in the symptomatic patients , . Nonetheless, there are three notable changes of the laboratory examinations, which is likely to offer some clues for the identification, management and prevention of asymtomatic cases. Firstly, the initial laboratory examinations showed that erythrocyte sedimentation ratio (ESR) increased in 10/15 cases. Considering of the less specificity and reproducibility, of course, it is true that ESR cannot be the sole clue to disease in asymptomatic state, which must combined with epidemiological link and other evidence; secondly, eight of the fifteen cases had decreased albumin; thirdly, twelve cases presented with abnormal electrolytes such as hypokalemia and hypomagnesium. The abnormality of the albumin and electrolytes may indicate the insufficient nutrition weaken the immune system. A diet supplementation especially on these elements should be considered for the asymptomatic cases. Fig 1
Fig. 1

Chest CT scans of four cases presenting with ground glass opacity or small patches of infiltrates.

Chest CT scans of four cases presenting with ground glass opacity or small patches of infiltrates. We agree with Wenjie Yang et al. that a normal chest CT scan cannot exclude the diagnosis of COVID-19. In their paper, 17 out of 149 (11.4%) symptomatic patients had normal chest CT findings on admission. And 12 out of the 17 patients kept being negative 10 days later. In our observation, chest CT scan was taken twice or three times for each case. Eleven cases did not show any significant lesions on all initial and imaging follow-ups. Therefore, the initial establishment of confirmatory diagnosis for COVID-19 must be a combination of exposure history and/or laboratory detection whether cases have symptoms, signs, imaging manifestations or not. Notably, the remaining four cases in our investigations showed ground glass opacity or small patchy infiltrates and recovered around 14 days, suggesting that people do not necessarily show any discomfort even with the typical imaging lesions. Twelve cases were confirmed by nasopharyngeal specimen initially while two cases proven by rectum swabs. And one case positive by nasopharyngeal, rectum and feces detection whose final twice RT-PCR negative time was 26 days whereas the time from the first positivity to the twice negativity for the remaining14 cases ranged from 8 to 16 days with the average negative time 11.93 days. All the urine specimen were negative. Most recently, Wang et al did the detection of this virus in different types of clinical specimens from the symptomatic patients and found that none of the urine specimens tested positive, in line with the results of our asymptomatic cases. The cycling threshold (Ct) of RT-PCR assay is negatively related to the viral load. Four cases presented with low Ct values less than 27. The results here suggested that in asymptomatic cases the initial viral loading can be high which has been linked to the ability of airborne transmission rather than the appearance of symptoms. The studies on SARS virus found the higher viral load in nasopharygeal the higher incidence of major impact on the airborne transmission, which played a major role during the outbreak in Hong Kong. The relationship between the Ct value and the transmissibility of SARS-CoV-2 virus in asymptomatic patients warrants further investigation. According to the Guideline, the broad spectrum antiviral of 1000mg ribavirin infusion was given to each case combined with airway spray of interferon-α1b 60μg bid. Either Kaletra (Lopinavir/Ritonavir tablets) 2 tablets, bid (8 cases), or Arbidol 200mg tid (7 cases) was administered simultaneously. In Kaletra group, five patients presented with epigastric discomfort or pain, anorexia, nausea, vomit or diarrhea after 1-4 days of administration. Three cases showed slightly elevated aminotransferase or bilirubin. And the symptoms and liver function were alleviated once suspension of Kaletra and ribavirin. We need to differentiate the symptoms caused by the drugs or due to the virus itself based on the response of stopping suspicious medicines. Here, the abnormalities on those cases were alleviated therefore probably due to the reverse response caused by antivirals. Clinically, considering the undefined high toxicity of SARS-Cov-2 virus, combination of antivirals were often administered for each case which is likely to result in confusing clinical situations. Our investigation showed that the asymptomatic cases of SARS-CoV-2 infection are not carriers or colonizers of the virus, thus this presentation may serve as a clinical spectrum of COVId-19. Its role deserves for further exploration and the potential as a source of infection needs to be carefully assessed in larger population.

Declaration of Competing Interest

None.
  4 in total

1.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

2.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 3.  [Asymptomatic forms of the Severe Acute Respiratory Syndrome (SARS)].

Authors:  M André; F Talarmin; P Le Guen; X Nicolas; J F Garcia; F Natali
Journal:  Rev Mal Respir       Date:  2005-02       Impact factor: 0.622

4.  Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China.

Authors:  Wenjie Yang; Qiqi Cao; Le Qin; Xiaoyang Wang; Zenghui Cheng; Ashan Pan; Jianyi Dai; Qingfeng Sun; Fengquan Zhao; Jieming Qu; Fuhua Yan
Journal:  J Infect       Date:  2020-02-26       Impact factor: 6.072

  4 in total
  8 in total

1.  SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.

Authors:  Johannes Korth; Benjamin Wilde; Sebastian Dolff; Olympia E Anastasiou; Adalbert Krawczyk; Michael Jahn; Sebastian Cordes; Birgit Ross; Stefan Esser; Monika Lindemann; Andreas Kribben; Ulf Dittmer; Oliver Witzke; Anke Herrmann
Journal:  J Clin Virol       Date:  2020-05-13       Impact factor: 3.168

2.  Epidemiological and clinical characteristics of a familial cluster of COVID-19.

Authors:  Yong Sun; Lin Tian; Xiaomei Du; Hua Wang; Yueshan Li; Rangbing Wu
Journal:  Epidemiol Infect       Date:  2020-07-07       Impact factor: 2.451

3.  [Pandemic management in a psychiatric care hospital : SARS-CoV-2 antibody tests as a tool for risk estimation].

Authors:  M Rentrop; T Winkler; T Wandersleb; P Zwanzger
Journal:  Nervenarzt       Date:  2021-03-17       Impact factor: 1.214

4.  Rapid Point-of-Care Testing for SARS-CoV-2 Virus Nucleic Acid Detection by an Isothermal and Nonenzymatic Signal Amplification System Coupled with a Lateral Flow Immunoassay Strip.

Authors:  Mingyuan Zou; Feiya Su; Rui Zhang; Xinglu Jiang; Han Xiao; XueJiao Yan; Chuankun Yang; Xiaobo Fan; Guoqiu Wu
Journal:  Sens Actuators B Chem       Date:  2021-04-03       Impact factor: 7.460

5.  Epidemiological, Radiographical, and Laboratorial Characteristics of Chinese Asymptomatic Cases With COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Haohao Yan; Yudan Ding; Wenbin Guo
Journal:  Front Public Health       Date:  2022-03-31

6.  Diagnostic Accuracy of a New Antigen Test for SARS-CoV-2 Detection.

Authors:  Marina Di Domenico; Alfredo De Rosa; Francesca Di Gaudio; Pietro Internicola; Cinzia Bettini; Nicola Salzano; Davide Castrianni; Andrea Marotta; Mariarosaria Boccellino
Journal:  Int J Environ Res Public Health       Date:  2021-06-10       Impact factor: 3.390

7.  Clinical features of patients with coronavirus disease 2019 from a designated hospital in Beijing, China.

Authors:  Lijun Sun; Lijun Shen; Junfen Fan; Fengjun Gu; Mei Hu; Yiran An; Qing Zhou; Huahao Fan; Jingfeng Bi
Journal:  J Med Virol       Date:  2020-06-12       Impact factor: 20.693

Review 8.  A Telemedicine Approach to Covid-19 Assessment and Triage.

Authors:  Allison B Reiss; Joshua De Leon; Isaac P Dapkins; George Shahin; Morgan R Peltier; Eric R Goldberg
Journal:  Medicina (Kaunas)       Date:  2020-09-10       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.